Tag: ORPH
Written by Ressie C. RileyAugust 30, 2021
ROSEN, A International AND Leading Regulation Organization, Encourages Orphazyme A/S Investors with Losses to Safe Counsel Before Essential Deadline in Securities Course Action – ORPH | Countrywide News
Law Firm Article
NEW YORK, Aug. 29, 2021 /PRNewswire/ — WHY: Rosen Legislation Organization, a world wide trader rights law agency, reminds purchasers of the securities of Orphazyme A/S (NASDAQ: ORPH): (1) pursuant and/or traceable to Orphazyme’s September 29, 2020 first public providing (the “IPO” or “Featuring”) and/or (2) in between September 29, 2020 and June 18, 2021, inclusive,